SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genomic Valley Biotech informs about AGM

31 Dec 2025 Evaluate

In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Genomic Valley Biotech has informed that the 31st Annual General Meeting (AGM) for the financial year 2024-25 of the company, held on Wednesday, 31st December, 2025 at 09:00 am at the Registered Office of the Company at 4 K.M. Stone, Berri Chharra Road Vill. Kherka, Musalman, P.O. Tandaheri Teh Bahadurgarh, Jhajjar, Haryana-124507, concluded at 09:30 am. The company has enclosed the Proceedings of the 31st Annual General Meeting held on Wednesday, 31st December, 2025.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Bio. Share Price

29.00 -0.88 (-2.95%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys (India) 1422.50
Mangalam Global Ent. 16.80
Kaveri Seed 917.15
Regaal Resources 83.90
Simran Farms 155.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: